首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >The WHO Classification of Lymphomas: Cost-effective Immunohistochemistry Using a Deductive Reasoning 'Decision Tree' Approach Part II: The Decision Tree Approach: Diffuse Patterns of Proliferation in Lymph Nodes
【24h】

The WHO Classification of Lymphomas: Cost-effective Immunohistochemistry Using a Deductive Reasoning 'Decision Tree' Approach Part II: The Decision Tree Approach: Diffuse Patterns of Proliferation in Lymph Nodes

机译:WHO淋巴瘤的分类:使用演绎推理“决策树”方法的经济有效的免疫组织化学第二部分:决策树方法:淋巴结中扩散的扩散模式

获取原文
获取原文并翻译 | 示例
           

摘要

The 2008 World Health Organization Classification of Tumors of the Haematopoietic and Lymphoid Tissues defines current standards of practice for the diagnosis and classification of malignant lymphomas and related entities. More than 50 different types of lymphomas are described. Faced with such a broad range of different lymphomas, some encountered only rarely, and a rapidly growing armamentarium of 80 or more pertinent immunohistochemical (IHC) "stains," the challenge to the pathologist is to use IHC in an efficient manner to arrive at an assured and timely diagnosis. This review uses deductive reasoning following a decision tree or dendrogram model, combining basic morphologic patterns and common IHC markers to classify node-based malignancies by the World Health Organization schema. The review is divided into 2 parts, the first addressing those lymphomas that produce a follicular or nodular pattern of lymph nodal involvement appeared in the previous issue of AIMM. The second part addresses diffuse proliferations in lymph nodes. Emphasis is given to the more common lymphomas and the more commonly available IHC "stains" for a pragmatic and practical approach that is both broadly feasible and cost-effective. By this method, an assured diagnosis may be reached in the majority of nodal lymphomas, at the same time developing a sufficiency of data to recognize those rare or atypical cases that require referral to a specialized center.
机译:《 2008年世界卫生组织造血和淋巴组织肿瘤分类》定义了目前的恶性淋巴瘤及相关实体诊断和分类的实践标准。描述了超过50种不同类型的淋巴瘤。面对如此广泛的各种淋巴瘤,一些淋巴瘤很少见,并且迅速发展的80多个或更多相关免疫组织化学(IHC)染色的武器集会,病理学家面临的挑战是以有效的方式使用IHC来达到保证及时诊断。这篇综述使用了决策树或树状图模型之后的演绎推理,结合了基本的形态学模式和常见的IHC标记,通过世界卫生组织的架构对基于结节的恶性肿瘤进行了分类。该综述分为两部分,第一部分针对的是那些产生滤泡或结节型淋巴结受累的淋巴瘤,出现在上一期AIMM中。第二部分解决淋巴结中的弥漫性增生。着重于较常见的淋巴瘤和较普遍使用的IHC“染色剂”,以务实和实用的方式广泛可行且具有成本效益。通过这种方法,可以在大多数淋巴瘤的大部分中得到确诊,同时开发出足够的数据来识别那些需要转诊至专门中心的罕见或非典型病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号